ATE526012T1 - Pharmazeutische formulierungen von meloxicam - Google Patents

Pharmazeutische formulierungen von meloxicam

Info

Publication number
ATE526012T1
ATE526012T1 AT09176632T AT09176632T ATE526012T1 AT E526012 T1 ATE526012 T1 AT E526012T1 AT 09176632 T AT09176632 T AT 09176632T AT 09176632 T AT09176632 T AT 09176632T AT E526012 T1 ATE526012 T1 AT E526012T1
Authority
AT
Austria
Prior art keywords
meloxicam
pharmaceutical formulations
meglumin
dimethylacetamide
oral
Prior art date
Application number
AT09176632T
Other languages
English (en)
Inventor
Ali Turkyilmaz
Hasan Ali Turp
Devdet Akdogan
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40847870&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE526012(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanovel Ilac Sanayi Ve Ticaret As filed Critical Sanovel Ilac Sanayi Ve Ticaret As
Application granted granted Critical
Publication of ATE526012T1 publication Critical patent/ATE526012T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
AT09176632T 2008-12-01 2009-11-20 Pharmazeutische formulierungen von meloxicam ATE526012T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2008/09200A TR200809200A1 (tr) 2008-12-01 2008-12-01 Meloksikam içeren farmasötik formülasyonlar

Publications (1)

Publication Number Publication Date
ATE526012T1 true ATE526012T1 (de) 2011-10-15

Family

ID=40847870

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09176632T ATE526012T1 (de) 2008-12-01 2009-11-20 Pharmazeutische formulierungen von meloxicam

Country Status (5)

Country Link
US (1) US20100137292A1 (de)
EP (1) EP2191820B1 (de)
AT (1) ATE526012T1 (de)
ES (1) ES2374626T3 (de)
TR (1) TR200809200A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100297252A1 (en) * 2003-03-03 2010-11-25 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
ES2609415T3 (es) * 2009-05-27 2017-04-20 Alkermes Pharma Ireland Limited Reducción de agregación laminar en composiciones con nanopartículas de meloxicam
JOP20200109A1 (ar) * 2012-04-23 2017-06-16 Otsuka Pharma Co Ltd مستحضر قابل للحقن
EP2703728B2 (de) † 2012-09-03 2023-11-08 BSH Hausgeräte GmbH Kochfeldvorrichtung
KR20210007951A (ko) 2018-05-11 2021-01-20 난징 델로바 바이오테크 컴퍼니 리미티드 멜록시캄 조성물, 제제 및 이의 제조 방법 및 응용
CN115068419A (zh) * 2022-07-22 2022-09-20 潍坊恒邦兽药有限公司 兽用高浓度美洛昔康注射剂及其加工设备

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2756113A1 (de) 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
WO1999009988A1 (en) * 1997-08-27 1999-03-04 Hexal Ag New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
EP0945134A1 (de) 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
WO2001037838A1 (fr) * 1999-11-24 2001-05-31 Wakamoto Pharmaceutical Co., Ltd. Preparation aqueuse ophtalmique
DE10030345A1 (de) 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
DE10250081A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Vetmedica Gmbh Wasserlösliche Meloxicam Granulate
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1972340A3 (de) * 2003-07-10 2008-11-26 Arturo Jimenez Bayardo Verfahren für die Zubereitung einer wässrigen Meloxicam-Lösung und auf diese Weise hergestellte wässrige Lösung
DE102004021281A1 (de) 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
US20070281927A1 (en) * 2006-06-06 2007-12-06 Shanthakumar Tyavanagimatt Anti-inflammatory and analgesic compositions and related methods
EP2293777B1 (de) 2008-06-24 2015-02-25 Intervet International B.V. Transdermale pharmazeutische zusammensetzung und verfahren zur behandlung von entzündungen bei rindern

Also Published As

Publication number Publication date
EP2191820A1 (de) 2010-06-02
ES2374626T3 (es) 2012-02-20
US20100137292A1 (en) 2010-06-03
EP2191820B1 (de) 2011-09-28
TR200809200A1 (tr) 2009-12-21

Similar Documents

Publication Publication Date Title
ATE526012T1 (de) Pharmazeutische formulierungen von meloxicam
EA200700653A1 (ru) Система контролируемой доставки
CY1120564T1 (el) Υδατικα εναιωρηματα tmc278
CY1124690T1 (el) Σκευασματα ενδοφλεβιου διαλυματος ποσακοναζολης σταθεροποιημενα με υποκατεστημενη βητα-κυκλοδεξτρινη
MD4577C1 (ro) Compoziţii masticabile de uz veterinar care conţin agent activ izoxazolinic şi utilizarea acestora în tratamentul sau prevenirea unei infestări sau infecţii parazitare
CY1118057T1 (el) Φαρμακευτικη συνθεση για στοματικη χορηγηση
CL2008003595A1 (es) Compuestos heterociclicos nitrogenados, antagonistas del receptor de taquiquinina; agente farmaceutico que comprende el compuesto; y uso en la profilaxis o el tratamiento de una enfermedad del tracto urinario inferior, una enfermedad gastrointestinal o una enfermedad del sistema nervioso central.
CY1114363T1 (el) Ανθελμινθικος συνδυασμος
EA200800360A1 (ru) Формуляции с высоким содержанием лекарства и дозированные формы
UY29108A1 (es) Ligandos de difenil éter terapéuticos
AR069211A1 (es) Derivados de acidos de 1,2,4-oxadiazol ciclobutanoamino carboxilicos, una composicion farmaceutica, proceso de preparacion del compuesto y su uso para preparar medicamentos
SV2011003907A (es) Composiciones antimicrobianas
RS53201B (en) BENDAMUSTIN ORAL DOSAGE FORMS
CY1111442T1 (el) Ενωσεις πιπεριδινης και χρησεις αυτων
EP4356968A3 (de) Langzeitwirkende formulierungen
PL2229938T3 (pl) Kompozycje ezetymibu
ATE364402T1 (de) Stabile injizierbare diclofenac- zubereitungen
MA32964B1 (fr) Formulation a effet retard d'octreotide avec niveau d'exposition constamment eleves
CL2022000875A1 (es) Inhibidores del factor d del complemento para administración oral
EA201291104A1 (ru) Пероральные лекарственные формы бендамустина
CY1112227T1 (el) Πιπεριδινυλαμινο-πυριδαζινες και η χρηση τους ως ταχεως διασπομενοι ανταγωνιστες υποδοχεα ντοπαμινης 2
NO20083183L (no) Fast farmasoytisk sammensetning inneholdende irbesartan
CY1119777T1 (el) Φαρμακευτικη συνθεση περιλαμβανουσα (1r,4r)-6'-φθοpo-n,n-διμεθυλ-4-φαινυλ-4',9'διυδρο-3'h-σπειρο[κυκλοεξανο-1,1'-πυρανο[3,4,β]ινδολ]-4-αμινη και γκαμπαπεντινοειδες
RU2007136310A (ru) Способ получения наноразмерной системы доставки лекарственных средств на основе диоксида кремния
CO6630124A2 (es) Terapia de combinación que comprende un antagonista de ccr5, un inhibidor de proteasa de vih-1, y un potenciador farmacocinético

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties